Pharmaceutical giant AstraZeneca on Thursday announced that clinical trials of an antibody-based Covid-19 drug had shown robust efficacy and long-term prevention. The Anglo-Swedish laboratory follows in the footsteps of US firms Merck and Pfizer, which ...
With intensive care beds filling up and health staff running short, a hospital in Bavaria’s Freising made an unprecedented decision to transfer a coronavirus patient to northern Italy for treatment. Through the highs and lows ...
GPs are pushing back against pressure to care for COVID-positive patients face to face, saying they do not have sufficient financial support to ensure it is done safely. Key points: GPs say a $25 Medicare ...
People travelling to Beijing will be subject to tighter COVID-19 control measures starting from Nov 17, the municipal government said Saturday. All those traveling into Beijing must provide negative results of nucleic acid tests taken ...